AbbVies
-
USA
British drug-cost watchdog recommends use of AbbVie’s ovarian cancer therapy
June 4 (Reuters) – The UK’s cost-effectiveness watchdog on Thursday recommended AbbVie’s “guided missile” cancer treatment Elahere for patients with…
Read More »